Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06488365 · ClinicalTrials.gov registry record · NA
In Vivo Liquid Biopsy of Melanoma (Cytophone)
A NA study of Melanoma and Metastatic Melanoma, sponsored by Cytoastra.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT06488365 is a NA study of Melanoma and Metastatic Melanoma that is actively recruiting participants, run by Cytoastra. The registered enrollment target is 180 participants, below the 706-participant average among 266 other Melanoma trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06488365, a NA study of Melanoma and Metastatic Melanoma, is actively recruiting participants, sponsored by Cytoastra.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
The Cytophone is a first in the world patented system to identify and count single circulating melanoma cells in blood circulation inside the human body. The Cytophone has a unique capability to find rare melanoma cells in the blood by an assessment of 100-500 times greater amounts of blood volume than routine blood tests. The important benefit of the Cytophone diagnosis is that the test does not require injection or any skin incision (i.e., non-invasiveness). The goal of this clinical trial is to demonstrate evidence of the capability of the Cytophone test to indicate a risk of metastasis and define CTC counts that correlate with melanoma recurrence, progression of metastatic disease, and therapy efficacy. The investigators believe that clinical trials will provide evidence that the Cytophone can diagnose risk of melanoma metastasis and recurrence earlier than existing methods.
Conditions Studied
Interventions
- DEVICE Cytophone
Study Locations (1)
Wisconsin
- SSM Health Dean Medical Group Specialty Services - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2025-02-11 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06488365
The ClinicalTrials.gov registry entry for NCT06488365 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 706-participant average among 266 other Melanoma trials with a reported enrollment target (75% lower). The listed sponsor is Cytoastra, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Melanoma appearing as the primary indexed condition, and to 1 intervention - of which Cytophone is the first listed.
NCT06488365 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06488365 about?
NCT06488365 is a clinical study titled "In Vivo Liquid Biopsy of Melanoma (Cytophone)". The Cytophone is a first in the world patented system to identify and count single circulating melanoma cells in blood circulation inside the human body. The Cytophone has a unique capability to find rare melanoma cells in the blood by an assessment of 100-500 times greater amounts of blood volume t...
What is the current status of trial NCT06488365?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2025-02-11. Estimated completion is 2026-03-31.
What conditions does trial NCT06488365 study?
This clinical trial studies the following conditions: Melanoma, Metastatic Melanoma, Diagnosis, Circulating Tumor Cells.
What interventions are being tested in trial NCT06488365?
The interventions under investigation include: Cytophone (DEVICE).
Who is sponsoring clinical trial NCT06488365?
This trial is sponsored by Cytoastra, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06488365 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Melanoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
RECRUITING · NA
-
Promoting Immunotherapy Efficacy With Low-Dose Liver RT
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
RECRUITING · NA
-
Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients
RECRUITING · NA
-
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.